Patients who are initially diagnosed with primary Gleason pattern 5 localized prostate cancer (i.e., having Gleason scores of 5 + 5 = 10 and 5 + 4 = 9) are well understood to have very high-risk disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: 5, Gleason, medicine, pattern, precision, risk | 3 Comments »
The answer to that question, at present, is that we don’t know — but it’s probably very few indeed compared to all the men who have progressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment | Tagged: genome, informed, oncology, precision, targeted | 1 Comment »
Knowing whether you carry inherited cancer risk genes can help you to make the best decisions for your treatment and for your family. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: counseling, genetic, medicine, precision, testing | 1 Comment »
A newly published paper in the journal JCO Precision Oncology confirms what many of us may have suspected — that the practical application of somatic tissue testing to clinical decision-making was low prior to 2015 . … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: genetic, genomic, genotyping, immunohistochemistry, medicine, molecular, precision, test | 25 Comments »
For interested readers, there will be a CureTalk this evening on precision medicine and the role of genetic/genomic testing in the selection of appropriate forms of treatment. It will not be prostate cancer-specific, but its role in prostate cancer will be addressed. … READ MORE …
Filed under: Uncategorized | Tagged: CureTalk, egnomic, precision, testing | Leave a comment »
As your sitemaster, let me be very clear about a couple of my most basic beliefs about prostate cancer and prostate cancer research. I want to do this because of all the recent media discussion about Vice President Byden’s “Moonshot” and the possible wonders of precision medicine. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: individualized, medicine, moonshot, precision, research | 16 Comments »
The print and online “Daily News” provided by the organizers of the Genitourinary Cancers Symposium here in Orlando offers additional articles today that may be of interest to many InfoLink readers. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, C-11 choline, medicine, PET, precision, PSA, radiation, screening | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 